Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 1.15 Million shares of FOLD, which is worth approximately $10.4 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 400 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $4,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M

29.78% 3M change

32.07% 12M change

Total Value Held $10.4 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	SELL Open market or private sale	$4,000 $10.0 p/Share	400 Reduced 0.03%	1,150,657 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	$3,611 $9.03 p/Share	400 Added 0.03%	1,151,057 Common Stock
Feb 11 2025	SELL Payment of exercise price or tax liability	$676,704 $9.57 p/Share	70,711 Reduced 5.79%	1,150,657 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	137,075 Added 10.1%	1,220,768 Common Stock
Jan 04 2025	SELL Payment of exercise price or tax liability	$69,332 $9.41 p/Share	7,368 Reduced 0.68%	1,083,693 Common Stock
Jan 03 2025	SELL Payment of exercise price or tax liability	$390,270 $9.41 p/Share	41,474 Reduced 3.66%	1,091,061 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	266,528 Added 19.05%	1,132,535 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$192,223 $9.31 p/Share	20,647 Reduced 2.33%	866,007 Common Stock
Dec 02 2024	SELL Open market or private sale	$75,150 $10.02 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Dec 02 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Nov 06 2024	SELL Open market or private sale	$98,762 $12.5 p/Share	7,901 Reduced 0.88%	886,654 Common Stock
Nov 06 2024	BUY Exercise of conversion of derivative security	$97,024 $12.28 p/Share	7,901 Added 0.88%	894,555 Common Stock
Nov 01 2024	SELL Open market or private sale	$85,950 $11.46 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Nov 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Oct 01 2024	SELL Open market or private sale	$79,500 $10.6 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Oct 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Sep 03 2024	SELL Open market or private sale	$87,825 $11.71 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Aug 01 2024	SELL Open market or private sale	$77,550 $10.34 p/Share	7,500 Reduced 0.84%	886,654 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$64,574 $8.61 p/Share	7,500 Added 0.83%	894,154 Common Stock
Jul 05 2024	SELL Open market or private sale	$61,000 $10.0 p/Share	6,100 Reduced 0.68%	886,654 Common Stock
Jul 05 2024	BUY Exercise of conversion of derivative security	$52,521 $8.61 p/Share	6,100 Added 0.68%	892,754 Common Stock
Jul 01 2024	SELL Open market or private sale	$14,000 $10.0 p/Share	1,400 Reduced 0.16%	886,654 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$12,054 $8.61 p/Share	1,400 Added 0.16%	888,054 Common Stock
Jun 03 2024	SELL Open market or private sale	$75,000 $10.0 p/Share	7,500 Reduced 0.84%	886,654 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account